CYAN Stock Overview
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$3.55|
|52 Week High||US$6.29|
|52 Week Low||US$2.61|
|1 Month Change||15.63%|
|3 Month Change||12.34%|
|1 Year Change||27.61%|
|3 Year Change||-4.05%|
|5 Year Change||-1.49%|
|Change since IPO||255.00%|
Recent News & Updates
Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|CYAN||US Personal Products||US Market|
Return vs Industry: CYAN exceeded the US Personal Products industry which returned 20.9% over the past year.
Return vs Market: CYAN exceeded the US Market which returned 20% over the past year.
|CYAN Average Weekly Movement||4.8%|
|Personal Products Industry Average Movement||9.4%|
|Market Average Movement||6.0%|
|10% most volatile stocks in US Market||15.0%|
|10% least volatile stocks in US Market||2.3%|
Stable Share Price: CYAN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CYAN's weekly volatility (5%) has been stable over the past year.
About the Company
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant that is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company sells its products as packaged consumer products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors.
Cyanotech Fundamentals Summary
|CYAN fundamental statistics|
Is CYAN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CYAN income statement (TTM)|
|Cost of Revenue||US$22.42m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.34|
|Net Profit Margin||6.09%|
How did CYAN perform over the long term?See historical performance and comparison
Is Cyanotech undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CYAN ($3.55) is trading above our estimate of fair value ($0.65)
Significantly Below Fair Value: CYAN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CYAN is good value based on its PE Ratio (10.4x) compared to the US Personal Products industry average (16.7x).
PE vs Market: CYAN is good value based on its PE Ratio (10.4x) compared to the US market (16.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CYAN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CYAN is good value based on its PB Ratio (1.2x) compared to the US Personal Products industry average (3x).
How is Cyanotech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cyanotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Cyanotech performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CYAN has a large one-off gain of $1.3M impacting its September 30 2021 financial results.
Growing Profit Margin: CYAN's current net profit margins (6.1%) are higher than last year (1.8%).
Past Earnings Growth Analysis
Earnings Trend: CYAN has become profitable over the past 5 years, growing earnings by 44.6% per year.
Accelerating Growth: CYAN's earnings growth over the past year (262.1%) exceeds its 5-year average (44.6% per year).
Earnings vs Industry: CYAN earnings growth over the past year (262.1%) exceeded the Personal Products industry 60.8%.
Return on Equity
High ROE: CYAN's Return on Equity (11.4%) is considered low.
How is Cyanotech's financial position?
Financial Position Analysis
Short Term Liabilities: CYAN's short term assets ($15.4M) exceed its short term liabilities ($4.6M).
Long Term Liabilities: CYAN's short term assets ($15.4M) exceed its long term liabilities ($7.6M).
Debt to Equity History and Analysis
Debt Level: CYAN's net debt to equity ratio (18.3%) is considered satisfactory.
Reducing Debt: CYAN's debt to equity ratio has reduced from 44.9% to 29.8% over the past 5 years.
Debt Coverage: CYAN's debt is well covered by operating cash flow (30.4%).
Interest Coverage: CYAN's interest payments on its debt are not well covered by EBIT (2.7x coverage).
What is Cyanotech current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CYAN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CYAN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CYAN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CYAN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CYAN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gerry Cysewski (72 yo)
Dr. Gerald R. Cysewski, also known as Gerry, Ph D., Co-Founded Cyanotech Corp. in 1983 and has been its Director since 1983. He serves as Vice Chairman at Cyanotech Corporation and serves as its Chief Exec...
CEO Compensation Analysis
Compensation vs Market: Gerry's total compensation ($USD124.01K) is below average for companies of similar size in the US market ($USD563.50K).
Compensation vs Earnings: Gerry's compensation has been consistent with company performance over the past year.
Experienced Management: CYAN's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Experienced Board: CYAN's board of directors are considered experienced (6.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cyanotech Corporation's employee growth, exchange listings and data sources
- Name: Cyanotech Corporation
- Ticker: CYAN
- Exchange: NasdaqCM
- Founded: 1983
- Industry: Personal Products
- Sector: Household
- Market Cap: US$21.989m
- Shares outstanding: 6.19m
- Website: https://www.cyanotech.com
Number of Employees
- Cyanotech Corporation
- 73-4460 Queen Kaahumanu Highway
- Suite 102
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/11/30 23:56|
|End of Day Share Price||2021/11/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.